methylphenidate (ritalin) behavioral studies in the rat

FILE PHOTO: A woman holds test tube in front of displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – Drugmaker Bristol Myers Squibb said on Thursday the U.S. Food and Drug Administration had approved its oral drug mavacamten for the treatment of a heart condition.